Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study

Detalles Bibliográficos
Autores principales: Hattori, Nobutaka, Kamei, Takanori, Ishida, Takayuki, Suzuki, Ippei, Nomoto, Masahiro, Tsuboi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550760/
https://www.ncbi.nlm.nih.gov/pubmed/36074303
http://dx.doi.org/10.1007/s00702-022-02543-z
_version_ 1784805952904495104
author Hattori, Nobutaka
Kamei, Takanori
Ishida, Takayuki
Suzuki, Ippei
Nomoto, Masahiro
Tsuboi, Yoshio
author_facet Hattori, Nobutaka
Kamei, Takanori
Ishida, Takayuki
Suzuki, Ippei
Nomoto, Masahiro
Tsuboi, Yoshio
author_sort Hattori, Nobutaka
collection PubMed
description
format Online
Article
Text
id pubmed-9550760
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-95507602022-10-12 Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study Hattori, Nobutaka Kamei, Takanori Ishida, Takayuki Suzuki, Ippei Nomoto, Masahiro Tsuboi, Yoshio J Neural Transm (Vienna) Correction Springer Vienna 2022-09-08 2022 /pmc/articles/PMC9550760/ /pubmed/36074303 http://dx.doi.org/10.1007/s00702-022-02543-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Hattori, Nobutaka
Kamei, Takanori
Ishida, Takayuki
Suzuki, Ippei
Nomoto, Masahiro
Tsuboi, Yoshio
Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
title Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
title_full Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
title_fullStr Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
title_full_unstemmed Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
title_short Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
title_sort correction: long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in parkinson’s disease: post-hoc analysis of a japanese phase iii study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550760/
https://www.ncbi.nlm.nih.gov/pubmed/36074303
http://dx.doi.org/10.1007/s00702-022-02543-z
work_keys_str_mv AT hattorinobutaka correctionlongtermeffectsofsafinamideadjuncttherapyonlevodopainduceddyskinesiainparkinsonsdiseaseposthocanalysisofajapanesephaseiiistudy
AT kameitakanori correctionlongtermeffectsofsafinamideadjuncttherapyonlevodopainduceddyskinesiainparkinsonsdiseaseposthocanalysisofajapanesephaseiiistudy
AT ishidatakayuki correctionlongtermeffectsofsafinamideadjuncttherapyonlevodopainduceddyskinesiainparkinsonsdiseaseposthocanalysisofajapanesephaseiiistudy
AT suzukiippei correctionlongtermeffectsofsafinamideadjuncttherapyonlevodopainduceddyskinesiainparkinsonsdiseaseposthocanalysisofajapanesephaseiiistudy
AT nomotomasahiro correctionlongtermeffectsofsafinamideadjuncttherapyonlevodopainduceddyskinesiainparkinsonsdiseaseposthocanalysisofajapanesephaseiiistudy
AT tsuboiyoshio correctionlongtermeffectsofsafinamideadjuncttherapyonlevodopainduceddyskinesiainparkinsonsdiseaseposthocanalysisofajapanesephaseiiistudy

Ejemplares similares